Aspire Biopharma Holdings, Inc. (ASBP)
NASDAQ: ASBP · Real-Time Price · USD
1.810
-0.100 (-5.24%)
At close: Jan 22, 2026, 4:00 PM EST
1.819
+0.009 (0.51%)
After-hours: Jan 22, 2026, 6:23 PM EST
Aspire Biopharma Holdings Market Cap
Aspire Biopharma Holdings has a market cap or net worth of $4.86 million as of January 22, 2026. Its market cap has decreased by -94.51% in one year.
Market Cap
4.86M
Enterprise Value
11.54M
1-Year Change
-94.51%
Ranking
Category
Stock Price
$1.81
Market Cap Chart
Since April 11, 2022, Aspire Biopharma Holdings's market cap has decreased from $349.65M to $4.86M, a decrease of -98.61%. That is a compound annual growth rate of -67.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 22, 2026 | 4.86M | -65.69% |
| Dec 31, 2025 | 14.18M | -84.12% |
| Dec 18, 2024 | 89.30M | -8.80% |
| Dec 29, 2023 | 97.91M | -73.55% |
| Dec 30, 2022 | 370.16M | 5.86% |
| Apr 11, 2022 | 349.65M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Can-Fite BioPharma | 5.46M |
| BiomX | 5.45M |
| Cyclerion Therapeutics | 5.25M |
| VivoSim Labs | 5.23M |
| Revelation Biosciences | 5.06M |
| GeoVax Labs | 4.95M |
| Silo Pharma | 4.91M |
| Decoy Therapeutics | 4.79M |